Upload
cardiacinfo
View
164
Download
1
Tags:
Embed Size (px)
DESCRIPTION
Citation preview
Australasian Society of Cardiothoracic Surgeons
(ASCTS)
Victorian Cardiac Surgery Database Project
Annual Report 2001-2002
Surgeons Report
Prepared by:
C.M. Reid, M. Rockell, P Skillington, G. Shardey on behalf of the ASCTS Database Project Steering Committee
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 1 of 834/10/2023
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 2 of 834/10/2023
2001 – 2002 First Annual Report For ASCTS Database
Mr. Peter SkillingtonPresident of Australasian Society of Cardiac and Thoracic
Surgeons
It is very pleasing to oversee the initial report, which covers the first year of data collection, for the ASCTS Database for Adult Cardiac Surgery. This is a comprehensive report for cardiac surgeons, which has been modeled on the Society of Cardiothoracic Surgeons of Great Britain and Ireland report. Many of you would have seen the initial public report for this time period of data collection (1/8/01 – 31/7/02), which was presented to the Victorian Government, to cover data collected for the six Victorian Public Hospitals which have participated in the database.
You will notice that there are three separate reports enclosed, as well as notes on the processes used. The three reports are as follows:
(a) Public Report – You have already seen this, it was delivered to the Victorian Department of Health in March, 2003.
(b) Comprehensive Surgeon’s Report – Detailed analysis of mortality and morbidity of CABG, valve, and other procedures, as well as analysis of results, depending on various pre-operative demographics and cardiac risk factors.
(c) In House Reporting Module – Each of the six Victorian Hospitals has the facility to print out a report of any particular period, according to this module. Thus, Victorian Units can compare their own results according to the module, with the overall results.
There is quite a bit of duplication present as a result of there being three reports, although it does provide a way for each Unit to quickly compare their own results with the overall cohort.
With the demise of the National Heart Foundation and AIHW Yearly Reports, we are proud to be able to present a comprehensive report on data collected, near contemporaneously. This report comes out approximately 15 months after the end of the data collection period. Our forthcoming Contract with the Victorian Government, will allow yearly reports to cover financial year periods (1st July – 30th June), and our contract states that these reports should be available within six months of the end of each collection period.
As yet, the ASCTS Database only operates in Victoria, although as many of you would be aware, much effort is proceeding to extend the database to other States as well as New Zealand. At the present time, the only risk modeling that has been performed is risk-adjusted mortality for isolated CABG, according to Euroscore. We hope to develop our own risk-adjustment model for isolated CABG, as well as other procedures, and complications, in due course.
I would like to thank all Members of ASCTS, who have worked to make this possible, both nationally with the development of the original dataset, definitions, ethical and peer review aspects, as well as to the individual Members of the Victorian Steering Committee. I would also like to thank the Victorian Department of Health Services for their ongoing support and funding of this endeavor, as well as Melbourne Information Management, and the Baker Heart Research Institute for the work that they have done on our behalf.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 3 of 834/10/2023
Foreword
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 4 of 834/10/2023
Introduction to the Annual Report of the ASCTS Database 7
Public Report (2001-2002) 11
Comprehensive Surgeon’s Report (2001-2002) 31
Valve data 32
Isolated CABG data 46
Other group data 56
Factors contributing to morbidity in the whole population 57
In-house reporting module – report for all units combined 63
Processes 73
Data Management 74
Peer Review Mechanism 75
Data Collection Form 76
Patient Information Sheet 82
Opt-off procedure 83
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 5 of 834/10/2023
Index
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 6 of 834/10/2023
Development of the ASCTS DatabaseThe proposal for a National Cardiothoracic Database was initiated by the Australasian Society of Cardiac and Thoracic Surgeons in 1996.The intent was to establish a system which would:
1. Assess the nature and outcomes of Cardiac surgery in Australasia.2. Provide Government and other interested Agencies with accurate,
validated, contemporaneous, risk-stratified information on surgical outcomes.
3. Allow patients access to information which will enhance informed consent.
4. Ensure the highest continuing standards of Cardiac surgery in Australasia.
This naturally demanded the following essentials:1. A minimum Dataset.2. Establishment of specific Definitions for the Dataset.3. Inclusion of all patients in the Database.4. Validation of all data.5. Risk adjustment, or Stratification, of outcome data.6. Contemporaneous availability of information.
Australian Cardiac surgery has a long history of data accumulation, initially through the NHF and subsequently the AIHW. However, this information was limited to numbers of procedures and mortality. It did not and could not comply with the requirements of the ASCTS.
Therefore a meeting to establish a Cardiac Surgical Database was held at Epworth Hospital in late 1997. The Victorian Government then established a consultative review to assess existing Cardiac Surgery Unit data collection systems and the feasibility of constructing a common database. This review recommended that the ASCTS initiative proceed.
Importantly, the Victorian DHS provided financial support for the Database project to proceed in Victoria, on condition that its practical feasibility was demonstrated. Accordingly, in July 2000, an Indicative Report, analyzing retrospectively collected data from five Victorian Cardiac surgical Units, was published. The Report demonstrated that a central agency could collect and generate comparative performance information. Significantly, it also confirmed that such information, harvested from several sources, each with their own collection systems and definitions, inevitably produced inaccurate and unreliable data.
Consequently, the ASCTS established a National Database Steering Committee and four subcommittees:
1. Dataset and Definitions.2. Data Analysis.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 7 of 834/10/2023
Introduction to the Annual Report of the ASCTS Database
3. Privacy and Ethics.4. Peer Review and Quality Assurance.
The deliberations of these Committees were presented and discussed at a National Cardiac Surgery Database workshop convened in Melbourne, in August, 2000.
Further encouragement for the project was provided by the publishing of unadjusted ‘league tables’ in the United States and United Kingdom and by evidence from the UK of the deleterious consequences of the absence of a National surgical outcome review. Specifically, the Victorian Government commissioned a Health Services Policy Review Discussion Paper which was published in 1999. Recommendation 24 of the Review stated “that the Commonwealth and States collaborate to develop a set of risk-adjusted, comprehensive, consumer-focused and current clinical performance indicators”.
The Victorian Government grant facilitated the creation of a Business Plan, produced by Melbourne Information Services and the appointment of the Cardio-Vascular Research Unit of the Baker Heart Research Institute as project managers. The Project was coordinated by a Steering Committee consisting of representatives from the participating Units and overseen by the Board of Australasian Cardiac Surgical Research Institution Limited.
The First Annual Report of the ASCTS DatabaseThe Report presents the results of prospectively collected data from all six Victorian Public Hospital Cardiac Surgical Units, from August 2001 to December 2002 inclusive. The methodology of data acquisition was rigorous. Identical information, in terms of Dataset and Definitions, was obtained from all Units.
The Report demonstrates that the outcomes of Victorian Units are acceptable, with no significant overall performance differences between units.
The FutureInclusion of All Australasian Cardiac Surgery UnitsThe ASCTS Database Project is now a reality. Its feasibility is demonstrated by this pilot project, which happened to take place in Victoria. As an integral component of the Project, a Software Program for data recording and reporting was generated. This would facilitate the adoption of the Database by any Unit. The next task is to progressively include all Australasian Units, in both the Public and Private sectors. All Units have expressed keen interest. However, lack of funding is a major impediment. Initiatives to obtain financial support have been instigated.
ResourcesA National project of this nature is expensive. Continued and stable funding is essential for data managers and their training, computer systems, the maintenance of database software, data transmission, validation processes, analysis and reporting programs and for central database personnel. Demonstrably, these costs are eclipsed by the benefits of the Database in terms of improved patient outcomes.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 8 of 834/10/2023
Modification of the Dataset and DefinitionsA dataset such as this must evolve. The current dataset was based on the US Society of Thoracic Surgeons (STS) model. Its application during the initial phase of the program has demonstrated necessary modifications consistent with Australasian requirements and progress in surgical techniques. Therefore, a review of the dataset and definitions will proceed at the end of this year. Nonetheless, the broad thrust of the program will be consistent with the established STS, UK and ECSUR Databases, in order to allow comparison.
Risk Adjustment and Risk Prediction ModelsSuch models, based on a variety of statistical techniques, have been developed by the UK and particularly the US STS Database Programs. Each recognizes that only models based on local data can validly reflect variation in clinical presentation and therefore outcomes. The development of such models requires large numbers of patients. Such numbers can only be acquired in a timely fashion if all Units contribute to the Program.
AcknowledgmentsThis Report was made possible by the vision and dedication of the members of the several Committees of the ASCTS, by the continuing involvement of all participating surgeons and allied health professionals, by the expertise and attention to detail of data managers and by the consistently superb contribution of the members of the Central Data Registry.
Finally, the ASCTS is grateful to DHS Victoria for its financial support and for its close and understanding involvement with the Project.
Gilbert C. Shardey FRACSChairman, ASCTS Cardiac Surgery Database Steering Committee
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 9 of 834/10/2023
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 10 of 834/10/2023
Public Report
This concise Public Report on the quality of cardiac surgical care provides accurate
information on the risk associated with cardiac surgery. A similar report is provided
for distribution to each individual participating cardiac surgery unit by the Victorian
Department of Human Services.
The Public Report covers some of the demographic and clinical characteristics of
people receiving cardiac surgery including information on:
Demographic characteristics of patients undergoing surgery in Victorian
Cardiac Surgery Units including:
Age and Gender distribution
Risk Factors
Aspects of Cardiac History
Types of operations undertaken in Victorian Cardiac Surgery Units
Raw, unadjusted Mortality by type of operation for procedures performed in
Victoria, the USA and the UK
Clinical Urgency Status of patients undergoing Surgery in Victorian Cardiac
Surgery Units
Mortality by patient clinical urgency status
Mortality by patient age for isolated CABG
The following key performance indicators have been identified for monitoring as
part of the report to the Victorian Government:
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 11 of 834/10/2023
Public Report
30 day all-cause risk-adjusted mortality following isolated CABG
Post-operative deep sternal infections following isolated CABG
Post-operative haemorrhage requiring return to theatre following isolated CABG
Length of ICU Stay following isolated CABG
Length of Intubation time following isolated CABG
All six Victorian Public Hospital Adult Cardiac Surgery Units have participated in
the program. They are The Austin and Repatriation Medical Centre, Geelong
Hospital, Monash Medical Centre – Clayton, Royal Melbourne Hospital, St
Vincent’s Hospital and The Alfred.
Demographic Characteristics
The majority (63%) of people receiving cardiac surgery services were aged 60 to
80 years (Figure 1). Females made up 30% of cardiac surgery patients. In terms
of risk factors, 18% of those having cardiac surgery were current smokers, 28%
had diabetes and 66% had high blood pressure requiring treatment. Other
characteristics of patients undergoing treatment at each of the hospitals are
indicated in Table 1.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 12 of 834/10/2023
Figure 1: Age distribution of all patients having Cardiac Surgery in Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 13 of 834/10/2023
80 + yrs
7%
70-79 yrs
33%
< 40 yrs
4%
40-49 yrs
7%
50-59 yrs
20%
60-69 yrs
30%
Table 1: Characteristics of Patients undergoing Surgery in Victorian Cardiac Surgical Units: 2001 - 2002
HospitalCharacteristic
A B C D E F Total
Total number of Cases included 627 507 418 334 344 760 2990Cases included in this analysis* 621 502 417 334 341 759 2974
Age and Sex DistributionMean Age (yr) 65 66 63 64 67 65 65>80 yrs (%) 9 5 2 7 7 8 7Males (%) 72 71 70 72 67 70 70
DOSAElective Day of Surgery Admission (%) 52 10 48 12 5 64 38
Risk FactorsCurrent Smoker (%) 17 24 19 13 18 18 18Diabetes (%) 28 25 28 25 25 32 28Hypertension(%) 59 66 66 63 55 79 66Cerebrovascular disease (%) 8 10 9 14 12 12 11Peripheral Vascular Disease (%) 14 11 12 9 12 11 12
Cardiac HistoryPrevious Cardiac Intervention (%) 21 13 14 20 18 17 17
Previous CABG (%) 8 4 3 5 4 4 5Previous Valve (%) 3 1 1 3 2 1 2Previous PTCA / Stent (%) 9 8 8 12 11 8 9
Myocardial Infarction (%) 42 43 41 40 46 43 43- of which <21days (%) 35 36 32 29 37 26 32
Congestive Heart Failure (%) 32 31 16 23 28 33 28*16 Procedures were excluded where 1) the procedure was a second procedure for a patient on the same day (50%), 2) where data on 30-day mortality, type of procedure or urgency status were missing (44%) or 3) where the patient had opted-off the database (6%)
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 14 of 834/10/2023
Types of Operations
Procedures that are performed in the cardiac surgery units include Coronary
Artery Bypass Graft Surgery (CABG) (68% of procedures), heart valve repair or
replacement (12%), a combination of both procedures (8%) with the remaining
12% of procedures being made up of all other less common cardiac procedures
or combinations of procedures.
Mortality by Type of Operation
The mortality rate for each of the three major groups of procedures is lower in
Victoria than that reported in published data from the USA and UK. The
mortality rate within thirty days of surgery for isolated CABG is around 2% (or
one death for every fifty patients). It should be noted that the “other” category,
which comprises only 12% of operations, includes a wide range of procedures,
many of which are associated with high risk. The overall mortality rate for this
mixed group of procedures is around 10% (Figure 2).
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 15 of 834/10/2023
Figure 2: Mortality rate for cardiac surgery by procedure group, USA, UK and Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 16 of 834/10/2023
Clinical Urgency Status for Isolated CABG and related mortality
Of the 2022 people undergoing isolated CABG between 1 August 2001 and 31
July 2002, 64% of people were admitted as elective patients, 30% of people
were operated upon as urgent cases, 5% of people were operated on as
emergency (that is within 24 hours of presentation) and <1% of people where
operated on as “salvage” procedures, that is where a life-threatening event had
already occurred (Figure 3).
The mortality rate for each of these patient groups is shown in Figure 4. The
mortality rate for people undergoing elective surgery is approximately one-tenth
the rate for emergency surgery.
Patient Age and Related Mortality
Older patients have less capacity to sustain cardiac surgery. This is reflected in
mortality rates for elective isolated CABG surgery with the increasing mortality
rate with increasing age shown in Figure 5. Despite this increase with age the
mortality rate for people 80 years and older peaks at 4% or approximately one
death per 25 people undergoing an operation.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 17 of 834/10/2023
Figure 3: Status of Patients undergoing Isolated CABG procedures, Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 18 of 834/10/2023
Salvage 0.8%
Emergency 5.2%
Urgent 29.8%
Elective 64.2%
Figure 4: Mortality rate for isolated CABG surgery by clinical urgency status of the patient, Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 19 of 834/10/2023
Figure 5: Mortality rate following elective isolated CABG surgery by Age Group, Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 20 of 834/10/2023
Performance Indicators
Comparison of Mortality for isolated CABG by Surgical Unit
The comparison between mortality rates (within 30 days of isolated CABG) for
all Victorian Public Hospital Cardiac Surgery Units as well as UK and USA
benchmarks is shown in Figure 6. The average Victorian Cardiac Surgery
mortality rate is below the rate for both the UK and the USA. Two Victorian
Cardiac Surgery Units had a mortality rate above the USA benchmark and
three hospitals had a rate above the UK benchmark. All hospitals in Victoria fell
within 3 standard deviations of the mean and are therefore not significantly
different in 30 day mortality outcomes.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 21 of 834/10/2023
Figure 6: The Mortality rate within 30 days of isolated Coronary Artery Bypass Graft Surgery (CABG), Victorian Public Hospitals, 1 August 2001 to 31 July 2002. The average mortality rate for UK and USA hospitals are shown with the large and small dashed lines respectively.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 22 of 834/10/2023
Number of deaths: 4 4 4 7 3 4 0 2 2 8 3 2
Figure 7: The Mortality rate within 30 days of Coronary Artery Bypass Graft Surgery (CABG), elective vs non-elective procedures, Victorian Public Hospitals, 1 August 2001 to 31 July 2002. Numbers represent the actual numbers of deaths in each category
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 23 of 834/10/2023
Post-operative Deep Sternal Infection and Haemorrhage
Deep sternal infection is a serious complication of CABG surgery. This
complication is rare (all units having an incidence of 1%), and hence is affected
by a small amount of random variation. Post-operative haemorrhage requiring
return to the operating theatre is not as serious a complication, but does impact on
theatre and blood bank utilisation. The deep sternal infection and return to theatre
for post-operative haemorrhage complication rates post CABG for each of the
Cardiac Surgery Units are shown in Figures 8 and 9 respectively. Although the
rates appear to differ between Cardiac Surgery Units, all Units have very low rates
and have performed well within the expected statistical limits. Whilst there is no
evidence of a statistical difference in these complication rates between Cardiac
Surgery Units, it is important to note that one hospital has reported no cases of
deep sternal infection over the 12 month period. This should be closely examined
further for strategies to improve the already low rates reported in other Units.
Length of Stay and Mechanical Ventilation
The length of stay in ICU and the period of time that a patient requires mechanical
ventilation (support to breathe) post-operatively are important cost measures of
cardiac surgical care. The need for mechanical ventilation is dependent on the
extent and complexity of the cardiac surgery being undertaken, the patient’s age
and the presence of obesity or pre-existing respiratory disease. The period of time
for which mechanical ventilation is required and the time spent in ICU are
interdependent, since mechanical ventilation is the most common reason
necessitating prolonged ICU care. Patients will usually require mechanical
ventilation after cardiac surgery. On occasions this will be for long periods of time
depending on the patient’s condition. The mean and median duration of time spent
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 24 of 834/10/2023
in ICU and spent intubated (on mechanical ventilation) in each Cardiac Surgery
Unit are shown in figures 10 and 11 respectively. The median times (which vary
little between Units) are more accurate indicators of each Units performance, as
outliers with prolonged times can distort the mean values.
Number of cases: 2 1 2 2 0 2 9* * - total number
Figure 8: Deep sternal infection rate following isolated CABG, Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 25 of 834/10/2023
Number of cases: 12 10 4 2 7 8 43*
* - total number
Figure 9: Rate of Post-operative haemorrhage requiring return to theatre following isolated CABG, Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 26 of 834/10/2023
Figure 10: Average and Median length of ICU stay in hours post isolated CABG, Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 27 of 834/10/2023
Figure 11: Average and Median length of Intubation time in hours post isolated CABG, Victorian Public Hospitals, 1 August 2001 to 31 July 2002
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 28 of 834/10/2023
Summary
In this report, it can be seen that the outcomes from cardiac surgery in Victorian
Public Hospitals are as good or better than equivalent overseas results, and that
there are no significant differences in the performance outcomes between the
individual units.
It is expected that the introduction of this database will result in further
improvements in the quality and outcome of care in Victorian patients having
cardiac surgery operations in the Public Hospital system.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 29 of 834/10/2023
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 30 of 834/10/2023
Comprehensive Surgeon’s Report
This Report provides a more comprehensive assessment of the data than the
Public Report. It gives the opportunity to look for emerging trends within the data,
and to drill down to look for inter-relationships between variables.
The Surgeon’s Report includes further data on the following:
Valve data
This section includes data on valve procedures, performed both with and without Coronary Artery Bypass Graft.
Data is presented on: Procedure typeProsthesis useMortalityPost-operative complicationsPost-operative indicators
Isolated CABG data
This section presents data for Isolated Coronary Artery Bypass Graft procedures.
Data is presented on: GraftsMortalityPost-operative complicationsPost-operative indicators
‘Other’ Group data
This section provides outcome data on operations other than valve and Coronary Artery Bypass Graft procedures, or where a combination of procedures not covered in the previous section were conducted in the same theatre episode.
Factors Contributing to Outcomes in the Whole Population
This section provides outcome data for all cardiac surgery procedures in relation to a number of risk factors.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 31 of 834/10/2023
Comprehensive Surgeon’s Report
Valve data
SINGLE VALVE OPERATIONSWITHOUT CABG WITH CABG
Initial Redo Total Total
No. Died % No. Died % No. Died % No. Died %
AorticAnnuloplasty only 0 - - 0 - - 0 - - 1 0 0.0
Replacement 189 5 2.6 11 1 9.1 200 6 3.0 176 9 5.1Root reconstruction with valve conduit
15 0 0.0 1 1 100.0 16 1 6.3 3 0 0.0
Resuspension 0 - - 1 1 100.0 1 1 100.0 0 - -Repair / Reconstruction with annuloplasty
0 - - 0 - - 0 - - 1 0 0.0
Repair / Reconstruction without annuloplasty
4 0 0.0 1 0 0.0 5 0 0.0 0 - -
Root reconstruction with valve sparing
2 0 0.0 0 - - 2 0 0.0 1 0 0.0
Resection sub aortic stenosis
1 0 0.0 0 - - 1 0 0.0 0 - -
Aortic total 211 5 2.4 14 3 21.4 225 8 3.6 182 9 4.9
MitralAnnuloplasty only 5 0 0.0 0 - - 5 0 0.0 6 0 0.0
Replacement 48 1 2.1 6 1 16.7 54 2 3.7 26 0 0.0Repair / Reconstruction with annuloplasty
37 0 0.0 0 - - 37 0 0.0 17 0 0.0
Repair / Reconstruction without annuloplasty
0 - - 1 0 0.0 1 0 0.0 0 - -
Mitral total 89 1 1.1 7 1 14.3 97 2 2.1 49 0 0.0
TricuspidReplacement 2 0 0.0 0 - - 2 0 0.0 0 - -Repair / Reconstruction with annuloplasty
1 0 0.0 0 - - 1 0 0.0 0 - -
Tricuspid total 3 0 0.0 0 - - 3 0 0.0 0 - -
PulmonaryReplacement 2 0 0.0 0 - - 2 0 0.0 0 - -
Pulmonary total 2 0 0.0 0 - - 2 0 0.0 0 - -
Total single valve 306 6 2.0 21 4 19.0 327 10 3.1 231 9 3.9
MULTIPLE VALVE OPERATIONS
Double valvesMitral & Aortic 18 1 5.6 1 1 100.0 19 2 10.5 3 0 0.0
Mitral & Tricuspid 4 1 25.0 2 1 50.0 6 2 33.3 2 0 0.0
Aortic & Tricuspid 2 0 0.0 0 - - 2 0 0.0 0 0 0.0
Other double valves 6 0 0.0 2 0 0.0 8 0 0.0 0 0 0.0
Double total 30 2 6.7 5 2 40.0 35 4 11.4 5 0 0.0
Triple total 3 0 0.0 1 0 0.0 4 0 0.0 0 - -
Total Multiple 33 2 6.1 6 2 33.3 39 4 10.3 5 0 0.0
Total single 306 6 2.0 21 4 19.0 327 10 3.1 231 9 3.9
Total valve 339 8 2.4 27 6 22.2 366 14 3.8 238 10 4.2
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 32 of 834/10/2023
Valve data
VALVE BY PROSTHESIS TYPE
Single valve without CABG
Valve Position
Aortic Mitral Tricuspid Pulmonary
n 225 97 3 2
None 3.6% 2.1% 0.0% 0.0%
Mechanical 34.7% 47.4% 0.0% 0.0%
Bioprosthesis 56.4% 6.2% 66.7% 50.0%
Homograft / Allograft 4.5% 1.0% 0.0% 50.0%
Autograft 0.0% 0.0% 0.0% 0.0%
Ring/Annuloplasty 0.9% 43.3% 33.3% 0.0%
Single valve with CABG
Valve Position
Aortic Mitral Tricuspid Pulmonary
n 182 49 0 0
None 0.5% 0.0% - -
Mechanical 25.3% 38.8% - -
Bioprosthesis 74.2% 12.2% - -
Homograft / Allograft 0.0% 2.0% - -
Autograft 0.0% 0.0% - -
Ring/Annuloplasty 0.0% 46.9% - -
Single valve with or without CABG
Valve Position
Aortic Mitral Tricuspid Pulmonary
n 407 146 3 2
None 2.2% 1.4% 0.0% 0.0%
Mechanical 30.5% 44.5% 0.0% 0.0%
Bioprosthesis 64.4% 8.2% 66.7% 50.0%
Homograft / Allograft 1.0% 1.4% 0.0% 50.0%
Autograft 1.5% 0.0% 0.0% 0.0%
Ring/Annuloplasty 0.5% 44.5% 33.3% 0.0%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 33 of 834/10/2023
Valve data
VALVE BY AETIOLOGY AND AGE
All Aortic valve procedures
Age Group<40
years40-49
yrs50-59
yrs60-69
yrs70-79
yrs80+ yrs
Total
n 25 31 60 133 197 81 527
Rheumatic 4.0% 9.7% 10.0% 11.3% 6.6% 3.7% 7.8%
Congenital 36.0% 25.8% 25.0% 21.1% 9.1% 4.9% 15.6%
Ischaemic 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Idiopathic Calcific 0.0% 19.4% 31.7% 42.9% 60.9% 71.6% 49.3%
Myxomatous degeneration 4.0% 6.5% 3.3% 9.8% 9.1% 12.3% 8.7%
Failed prior repair 0.0% 3.2% 0.0% 0.0% 0.0% 0.0% 0.2%
Prosthetic valve failure 4.0% 0.0% 0.0% 0.0% 1.5% 1.2% 0.9%
Peri-prosthetic leak 0.0% 0.0% 1.7% 0.0% 0.5% 0.0% 0.4%
Prosthetic valve thrombosis 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Active infection 20.0% 9.7% 11.7% 3.0% 3.6% 1.2% 5.1%
Previous infection 8.0% 0.0% 0.0% 1.5% 0.0% 0.0% 0.8%
Marfans 8.0% 3.2% 0.0% 0.8% 0.0% 0.0% 0.8%
Annuloaortic ectasia 0.0% 0.0% 6.7% 3.8% 2.5% 2.5% 3.0%
Other degenerative disease 4.0% 6.5% 0.0% 0.8% 1.5% 0.0% 1.3%
Dissection 4.0% 12.9% 8.3% 4.5% 0.5% 0.0% 3.2%
Tumour 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Trauma 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Iatrogenic 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Other 4.0% 0.0% 1.7% 0.8% 2.5% 1.2% 1.8%
Not specified 4.0% 3.2% 0.0% 0.0% 1.5% 1.2% 1.1%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 34 of 834/10/2023
Valve data
VALVE BY AETIOLOGY AND AGE
All Mitral valve procedures
Age Group<40
years40-49
yrs50-59
yrs60-69
yrs70-79
yrs80+ yrs
Total
n 18 14 31 73 73 11 220
Rheumatic 5.6% 42.9% 35.5% 28.8% 17.8% 9.1% 24.1%
Congenital 11.1% 0.0% 3.2% 0.0% 1.4% 0.0% 1.8%
Ischaemic 0.0% 0.0% 3.2% 9.6% 19.2% 0.0% 10.0%
Idiopathic Calcific 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Myxomatous degeneration 16.7% 35.7% 29.0% 47.9% 46.6% 54.5% 41.8%
Failed prior repair 11.1% 7.1% 3.2% 0.0% 2.7% 0.0% 2.7%
Prosthetic valve failure 0.0% 0.0% 0.0% 0.0% 1.4% 0.0% 0.5%
Peri-prosthetic leak 5.6% 0.0% 3.2% 1.4% 1.4% 9.1% 2.3%
Prosthetic valve thrombosis 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Active infection 33.3% 7.1% 9.7% 1.4% 2.7% 9.1% 6.4%
Previous infection 5.6% 0.0% 3.2% 1.4% 0.0% 0.0% 1.4%
Marfans 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Other degenerative disease 0.0% 0.0% 0.0% 1.4% 1.4% 0.0% 0.9%
Dissection 0.0% 0.0% 0.0% 1.4% 0.0% 0.0% 0.5%
Tumour 5.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5%
Trauma 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Iatrogenic 0.0% 0.0% 0.0% 0.0% 1.4% 0.0% 0.5%
Other 5.6% 0.0% 9.7% 5.5% 1.4% 9.1% 4.5%
Not specified 0.0% 7.1% 0.0% 1.4% 2.7% 9.1% 2.3%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 35 of 834/10/2023
Valve data
Mortality
SUMMARY
Number of Operations
30 day Mortality (n)
30 day Mortality (%)
Valves only
Aortic Valve Surgery only 225 8 3.6%
Aortic Valve Replacement only 200 6 3.0%
Mitral Valve Surgery only 99 2 2.0%
Mitral Valve Replacement only 54 2 3.6%
MV Repair only 38 0 0.0%
Tricuspid Valve Surgery only 3 0 0.0%
Pulmonary Valve Surgery only 2 0 0.0%
Aortic & Mitral Valve Surgery only 19 2 10.5%
Mitral & Tricuspid Valve Surgery only 6 2 33.3%
Aortic & Tricuspid Valve Surgery only 2 0 0.0%
Other Doubles 8 0 0.0%
Triples 4 0 0.0%
Valves & CABG only
Aortic Valve Surgery & CABG only 182 9 4.9%
Aortic Valve Replacement & CABG only 176 9 5.1%
Mitral Valve Surgery & CABG only 49 0 0.0%
Mitral Valve Replacement & CABG only 26 0 0.0%
Mitral Valve Repair & CABG only 17 0 0.0%
Aortic & Mitral Valve Surgery & CABG only 3 0 0.0%
Mitral & Tricuspid Valve Surgery & CABG only 2 0 0.0%
TOTAL Valve (with or without CABG) only
604 24 4.0%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 36 of 834/10/2023
Valve data
SINGLE VALVE – INITIAL OPERATION ONLYMortality
BY CARDIAC SURGERY UNIT
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 37 of 834/10/2023
Valve data
Mortality
BY AGE
Single valve with or without CABG
30 day Mortality (mortality/n %)
Age Group
<40 years 40-49 yrs 50-59 yrs 60-69 yrs 70-79 yrs 80+ yrs
Aortic 1/12 8.3% 0/16 0.0% 0/40 0.0% 3/99 3.0% 6/172 3.5% 7/68 10.3%
Mitral 0/6 0.0% 0/7 0.0% 0/22 0.0% 0/50 0.0% 2/53 3.8% 0/8 0.0%
Tricuspid 0/1 0.0% 0/1 0.0% 0/0 - 0/1 0.0% 0/0 - 0/0 -
Pulmonary 0/2 0.0% 0/0 - 0/0 - 0/0 - 0/0 - 0/0 -
Total 1/21 4.8% 0/24 0.0% 0/62 0.0% 3/150 2.0% 8/225 3.6% 7/76 9.2%
AVR + CABG only
30 day Mortality (mortality/n %)
Age Group
<40 years 40-49 yrs 50-59 yrs 60-69 yrs 70-79 yrs 80+ yrs
0/0 - 0/2 0.0% 0/8 0.0% 3/41 6.8% 1/91 1.1% 5/32 15.2%
BY CLINICAL STATUS
AVR + CABG only30 day Mortality (mortality/n %)
Operative Status
Elective Urgent Emergency Salvage
6/136 4.4% 3/36 8.3% 0/1 0.0% 0/1 0.0%
AVR + CABG only30 day Mortality (mortality/n %)
Redo Pre-op creatinine
Yes No <=0.2 >0.2
1/15 6.7% 8/159 5.0% 7/164 4.3% 2/10 20.0%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 38 of 834/10/2023
Valve data
Morbidity
BY VALVE POSITION
Single valve – Valve only
Post-operative complications
Valve Position
Aortic MitralTricuspid or Pulmonary Total
n 225 97 5 327
New Renal Failure 5.3% 2.1% 0.0% 4.3%
Cerebrovascular complication 3.1% 1.0% 0.0% 2.4%
Permanent Stroke 2.2% 1.0% 0.0% 1.8%
Transient Stroke 0.4% 0.0% 0.0% 0.3%
Continuous Coma 0.4% 0.0% 0.0% 0.3%
Deep Sternal Infection 0.0% 0.0% 0.0% 0.0%
Septicaemia 0.9% 1.0% 0.0% 0.9%
Return to theatre (all cause) 9.8% 7.2% 0.0% 8.9%
Re-op for Bleeding 6.7% 5.2% 0.0% 6.1%
Peri-operative AMI 0.4% 0.0% 0.0% 0.3%
New Cardiac Arrhythmia 36.9% 34.0% 0.0% 35.5%
Pneumonia 5.3% 5.2% 0.0% 5.2%
GIT complication 1.8% 1.0% 0.0% 1.5%
Multi-system Failure 0.9% 1.0% 0.0% 0.9%
Anticoagulant complication 0.4% 1.0% 0.0% 0.6%
Red Blood Cells transfused 47.6% 38.1% 40.0% 44.6%
Non-RBC blood products 28.9% 22.7% 0.0% 26.6%
Post-operative indicators Intubation Time <=10hrs 57.9% 70.8% 80.0% 62.1%
10-20hrs 30.3% 24.0% 20.0% 28.3%
>20hrs 11.8% 5.2% 0.0% 9.6%
Post-op Length of Stay
<= 5 days 19.1% 15.5% 0.0% 17.7%
5-10 days 59.6% 59.8% 80.0% 59.9%
>10 days 21.3% 24.7% 20.0% 22.3%
Intensive Care Stay
<=24hrs 54.3% 59.8% 40.0% 55.7%
>24hrs –4 days
38.1% 35.1% 60.0% 37.5%
> 4 days 7.6% 5.2% 0.0% 6.8%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 39 of 834/10/2023
Valve data
Morbidity
BY VALVE POSITION
Single valve – Valve with CABG only
Post-operative complications
Valve Position
Aortic MitralTricuspid or Pulmonary Total
n 182 49 0 231
New Renal Failure 12.1% 8.2% - 11.3%
Cerebrovascular complication 3.3% 8.2% - 4.3%
Permanent Stroke 1.1% 6.1% - 2.2%
Transient Stroke 2.2% 0.0% - 1.7%
Continuous Coma 0.0% 2.0% - 0.4%
Deep Sternal Infection 0.5% 2.0% - 0.9%
Septicaemia 2.7% 4.1% - 3.0%
Return to theatre (all cause) 5.5% 10.2% - 6.5%
Re-op for Bleeding 3.8% 8.2% - 4.8%
Peri-operative AMI 2.2% 0.0% - 1.7%
New Cardiac Arrhythmia 42.9% 44.9% - 43.3%
Pneumonia 7.7% 14.3% - 9.1%
GIT complication 3.8% 2.0% - 3.5%
Multi-system Failure 3.3% 2.0% - 3.0%
Anticoagulant complication 2.2% 2.0% - 2.2%
Red Blood Cells transfused 66.5% 65.3% - 66.2%
Non-RBC blood products 45.6% 36.7% - 43.7%
Post-operative indicators Intubation Time <=10hrs 47.8% 34.7% - 45.0%
10-20hrs 34.6% 26.5% - 32.9%
>20hrs 17.6% 38.8% - 22.1%
Post-op Length of Stay
<= 5 days 8.8% 10.2% - 9.1%
5-10 days 53.3% 44.9% - 51.5%
>10 days 37.9% 44.9% - 39.4%
Intensive Care Stay
<=24hrs 36.3% 28.6% - 34.6%
>24hrs –4 days
48.9% 49.0% - 48.9%
> 4 days 14.8% 22.4% - 16.5%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 40 of 834/10/2023
Valve data
Morbidity
BY VALVE POSITION
Single valve – Valve with or without CABG only
Post-operative complications
Valve Position
Aortic MitralTricuspid or Pulmonary Total
n 407 146 5 558
New Renal Failure 9.8% 4.1% 0.0% 7.2%
Cerebrovascular complication 3.2% 3.4% 0.0% 3.2%
Permanent Stroke 1.7% 2.7% 0.0% 2.0%
Transient Stroke 1.2% 0.0% 0.0% 0.9%
Continuous Coma 0.2% 0.7% 0.0% 0.3%
Deep Sternal Infection 0.2% 0.7% 0.0% 0.3%
Septicaemia 1.7% 2.1% 0.0% 1.8%
Return to theatre (all cause) 7.9% 11.0% 0.0% 7.9%
Re-op for Bleeding 5.4% 6.2% 0.0% 5.6%
Peri-operative AMI 1.2% 0.0% 0.0% 0.9%
New Cardiac Arrhythmia 39.6% 37.7% 0.0% 38.7%
Pneumonia 6.4% 8.2% 0.0% 6.8%
GIT complication 2.7% 1.4% 0.0% 2.3%
Multi-system Failure 2.0% 1.4% 0.0% 1.8%
Anticoagulant complication 1.2% 1.4% 0.0% 1.3%
Red Blood Cells transfused 56.0% 47.3% 40.0% 53.6%
Non-RBC blood products 36.4% 27.4% 0.0% 33.7%
Post-operative indicators Intubation Time <=10hrs 52.8% 58.2% 80.0% 54.5%
10-20hrs 31.9% 26.7% 20.0% 29.9%
>20hrs 14.3% 16.4% 0.0% 14.7%
Post-op Length of Stay
<= 5 days 14.5% 13.7% 0.0% 14.2%
5-10 days 56.8% 54.8% 80.0% 56.5%
>10 days 28.7% 31.5% 20.0% 29.4%
Intensive Care Stay
<=24hrs 45.9% 49.3% 40.0% 46.8%
>24hrs –4 days
42.8% 39.7% 60.0% 42.1%
> 4 days 10.8% 11.0% 0.0% 10.8%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 41 of 834/10/2023
Valve data
Morbidity
BY VALVE POSITION AND CARDIAC SURGERY UNIT
Single valve – Valve only
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 42 of 834/10/2023
No. cases
Aortic
A 49B 45C 33D 23E 25F 50
Total 225
Mitral
A 15B 24C 13D 8E 12F 25
Total 97
Valve data
Morbidity
BY AGE
Single valve – Valve only
Post-operative complications
Age Group<40
years40-49
yrs50-59
yrs60-69
yrs70-79
yrs80+ yrs
Total
n 21 22 47 87 109 41 327
New Renal Failure 0.0% 0.0% 0.0% 1.1% 7.3% 12.2% 4.3%
Cerebrovascular complication 0.0% 4.5% 0.0% 2.3% 3.7% 2.4% 2.4%
Permanent Stroke 0.0% 4.5% 0.0% 1.1% 2.8% 2.4% 1.8%
Transient Stroke 0.0% 0.0% 0.0% 1.1% 0.0% 0.0% 0.3%
Continuous Coma 0.0% 0.0% 0.0% 0.0% 0.9% 0.0% 0.3%
Deep Sternal Infection 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Septicaemia 4.8% 0.0% 0.0% 0.0% 0.9% 2.4% 0.9%
Return to theatre (all cause) 23.8% 9.1% 6.4% 9.2% 8.3% 4.9% 8.9%
Re-op for Bleeding 14.3% 0.0% 6.4% 6.9% 6.4% 2.4% 6.1%
Peri-operative AMI 0.0% 0.0% 0.0% 0.0% 0.9% 0.0% 0.3%
New Cardiac Arrhythmia 19.0% 27.3% 27.7% 39.1% 37.6% 43.9% 35.5%
Pneumonia 9.5% 0.0% 6.4% 1.1% 6.4% 9.8% 5.2%
GIT complication 4.8% 0.0% 2.1% 0.0% 2.8% 0.0% 1.5%
Multi-system Failure 0.0% 4.5% 0.0% 0.0% 1.8% 0.0% 0.9%
Anticoagulant complication 0.0% 0.0% 0.0% 1.1% 0.9% 0.0% 0.6%
Red Blood Cells transfused 52.4% 36.4% 34.0% 29.9% 54.1% 63.4% 44.6%
Non-RBC blood products 33.3% 31.8% 21.3% 24.1% 27.5% 29.3% 26.6%
Post-operative indicators
Intubation Time <=10hrs 65.0% 76.2% 61.7% 76.7% 52.3% 48.8% 62.1%
10-20hrs 25.0% 9.5% 34.0% 18.6% 34.6% 36.6% 28.3%
>20hrs 10.0% 14.3% 4.3% 4.7% 13.1% 14.6% 9.6%
Post-op Length of Stay
<= 5 days 19.0% 22.7% 23.4% 24.1% 14.7% 2.4% 17.7%
5-10 days 33.3% 54.5% 55.3% 58.6% 63.3% 75.6% 59.9%
>10 days 47.6% 22.7% 21.3% 17.2% 22.0% 22.0% 22.3%
Intensive Care Stay
<=24hrs 52.4% 45.5% 63.8% 64.4% 55.1% 36.6% 55.7%
>24hrs –4 days
38.1% 40.9% 34.0% 32.2% 36.4% 53.7% 37.5%
> 4 days 9.5% 13.6% 2.1% 3.4% 8.4% 9.8% 6.8%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 43 of 834/10/2023
Valve data
Morbidity
BY AGE
Single valve – Valve with CABG only
Post-operative complications
Age Group<40
years40-49
yrs50-59
yrs60-69
yrs70-79
yrs80+ yrs
Total
n 0 2 15 63 116 35 231
New Renal Failure - 0.0% 6.7% 12.7% 6.9% 25.7% 11.3%
Cerebrovascular complication - 0.0% 0.0% 3.2% 4.3% 8.6% 4.3%
Permanent Stroke - 0.0% 0.0% 3.2% 1.7% 2.9% 2.2%
Transient Stroke - 0.0% 0.0% 0.0% 1.7% 5.7% 1.7%
Continuous Coma - 0.0% 0.0% 0.0% 0.9% 0.0% 0.4%
Deep Sternal Infection - 0.0% 0.0% 1.6% 0.9% 0.0% 0.9%
Septicaemia - 0.0% 6.7% 1.6% 1.7% 8.6% 3.0%
Return to theatre (all cause) - 0.0% 0.0% 9.5% 5.2% 8.6% 6.5%
Re-op for Bleeding - 0.0% 0.0% 9.5% 2.6% 5.7% 4.8%
Peri-operative AMI - 0.0% 0.0% 1.6% 1.7% 2.9% 1.7%
New Cardiac Arrhythmia - 50.0% 26.7% 42.9% 42.2% 54.3% 43.3%
Pneumonia - 0.0% 6.7% 6.3% 8.6% 17.1% 9.1%
GIT complication - 0.0% 0.0% 3.2% 3.4% 5.7% 3.5%
Multi-system Failure - 0.0% 6.7% 0.0% 2.6% 8.6% 3.0%
Anticoagulant complication - 0.0% 0.0% 3.2% 0.9% 5.7% 2.2%
Red Blood Cells transfused - 50.0% 40.0% 61.9% 68.1% 80.0% 66.2%
Non-RBC blood products - 50.0% 13.3% 44.4% 44.8% 51.4% 43.7%
Post-operative indicators
Intubation Time <=10hrs - 50.0% 46.7% 47.6% 44.0% 42.9% 45.0%
10-20hrs - 50.0% 26.7% 31.7% 36.2% 25.7% 32.9%
>20hrs - 0.0% 26.7% 20.6% 19.8% 31.4% 22.1%
Post-op Length of Stay
<= 5 days - 0.0% 26.7% 14.3% 5.2% 5.7% 9.1%
5-10 days - 50.0% 40.0% 47.6% 55.2% 51.4% 51.5%
>10 days - 50.0% 33.3% 38.1% 39.7% 42.9% 39.4%
Intensive Care Stay
<=24hrs - 0.0% 60.0% 38.1% 37.1% 11.4% 34.6%
>24hrs –4 days
- 100.0% 20.0% 47.6% 47.4% 65.7% 48.9%
> 4 days - 0.0% 20.0% 14.3% 15.5% 22.9% 16.5%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 44 of 834/10/2023
Valve data
Morbidity
BY AGE
Multiple valve – Valves onlyPost-operative complications
Age Group<40
years40-49
yrs50-59
yrs60-69
yrs70-79
yrs80+ yrs
Total
n 11 4 9 11 4 0 39
New Renal Failure 9.1% 0.0% 0.0% 0.0% 0.0% - 2.6%
Cerebrovascular complication 0.0% 0.0% 0.0% 9.1% 0.0% - 2.6%
Permanent Stroke 0.0% 0.0% 0.0% 0.0% 0.0% - 0.0%
Transient Stroke 0.0% 0.0% 0.0% 0.0% 0.0% - 0.0%
Continuous Coma 0.0% 0.0% 0.0% 9.1% 0.0% - 2.6%
Deep Sternal Infection 0.0% 0.0% 0.0% 0.0% 0.0% - 0.0%
Septicaemia 18.2% 0.0% 0.0% 0.0% 0.0% - 5.1%
Return to theatre (all cause) 9.1% 0.0% 11.1% 0.0% 0.0% - 5.1%
Re-op for Bleeding 0.0% 0.0% 11.1% 0.0% 0.0% - 2.6%
Peri-operative AMI 0.0% 0.0% 0.0% 0.0% 0.0% - 0.0%
New Cardiac Arrhythmia 27.3% 50.0% 11.1% 27.3% 75.0% - 30.8%
Pneumonia 9.1% 0.0% 0.0% 9.1% 0.0% - 5.1%
GIT complication 9.1% 0.0% 11.1% 0.0% 0.0% - 5.1%
Multi-system Failure 18.2% 0.0% 0.0% 9.1% 0.0% - 7.7%
Anticoagulant complication 0.0% 0.0% 0.0% 0.0% 0.0% - 0.0%
Red Blood Cells transfused 36.4% 25.0% 22.2% 36.4% 50.0% - 33.3%
Non-RBC blood products 54.5% 25.0% 44.4% 45.5% 25.0% - 43.6%
Post-operative indicators
Intubation Time <=10hrs 72.7% 75.0% 44.4% 54.5% 0.0% - 53.8%
10-20hrs 9.1% 25.0% 55.6% 27.3% 100.0% - 35.9%
>20hrs 18.2% 0.0% 0.0% 18.2% 0.0% - 10.3%
Post-op Length of Stay
<= 5 days 9.1% 25.0% 11.1% 18.2% 0.0% - 12.8%
5-10 days 72.7% 75.0% 66.7% 63.6% 50.0% - 66.7%
>10 days 18.2% 0.0% 22.2% 18.2% 50.0% - 20.5%
Intensive Care Stay
<=24hrs 27.3% 25.0% 22.2% 54.5% 0.0% - 30.8%
>24hrs –4 days
63.6% 75.0% 66.7% 27.3% 75.0% - 56.4%
> 4 days 9.1% 0.0% 11.1% 18.2% 25.0% - 12.8%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 45 of 834/10/2023
Isolated CABG data
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 46 of 834/10/2023
Number of ProceduresTotal Number of procedures Redo Surgery
NumberMortality
(30 days post op)Number
Mortality(30 days post op)
Procedure type
Number of procedures
% of Isolated CABG
Number% of
Procedure type
Number of procedures
% of Redo
Number
% of Procedure
type (redo)
Isolated CABG On Pump
1738 86.0% 43 2.5% 92 94.8% 4 4.3%
Isolated CABG Off Pump
284 14.0% 2 0.7% 5 5.2% 0 0.0%
TOTAL 2022 100.0% 45 2.2% 97 100.0% 4 4.1%
Number of distal anastomoses
Procedure type
Total number of procedures
X 1 X 2 X 3 X 4 X 5 X 6 X 7Mean
no. grafts
Isolated CABG On Pump
1738 34 283 734 534 132 17 4 3.3
Isolated CABG Off Pump
284 62 115 69 25 8 3 2 2.4
TOTAL 2022 96 389 803 559 140 20 6 3.2
Arterial grafts
Procedure type
Total number of procedures
All arterial T or Y graftsNumber of procedures
% of procedure type
Number of procedures
% of procedure type
Isolated CABG On Pump
1738 997 57.4% 183 10.5%
Isolated CABG Off Pump
284 275 96.8% 124 43.7%
TOTAL 2022 1272 62.9% 307 15.2%
Conduits used
Procedure type
Total number of procedures
Number of IMA conduits (mutually exclusive)
Number of RAD (mutually exclusive)
Number of GEPA
procedures
Number of SVG
proceduresLIMA RIMA BIMA RAD x 1 RAD x 2Isolated CABG On Pump
1738 1340 23 277 903 435 1 741
Isolated CABG Off Pump
284 249 5 25 163 7 0 9
TOTAL 2022 1589 28 302 1066 442 1 750
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 47 of 834/10/2023
Isolated CABG data
Patient characteristics
BY CARDIAC SURGERY UNIT
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 48 of 834/10/2023
No. cases
A 405B 347C 307D 195E 250F 518
Total 2022
Isolated CABG data
Patient characteristics
BY CARDIAC SURGERY UNIT
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 49 of 834/10/2023
No. cases
A 405B 347C 307D 195E 250F 518
Total 2022
Isolated CABG data
Patient characteristics
BY CARDIAC SURGERY UNIT
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 50 of 834/10/2023
No. cases
A 405B 347C 307D 195E 250F 518
Total 2022
Isolated CABG data
Mortality
BY AGE
30 day Mortality (mortality/n %)
Age Group
<40 years 40-49 yrs 50-59 yrs 60-69 yrs 70-79 yrs 80+ yrs
0/14 0.0% 1/143 0.7% 5/454 1.1% 11/636 1.7% 22/675 3.3% 6/100 6.0%
BY OPERATIVE STATUS
30 day Mortality (mortality/n %)
Operative Status
Elective Urgent Emergency Salvage
16/1267 1.3% 19/675 2.8% 9/73 12.3% 1/7 14.3%
BY PRE-OPERATIVE AMI
30 day Mortality (mortality/n %)Pre-op AMI Time since AMI
Yes No <6hrs 6-24hrs 1-7days 7-21days >21days
34/1051 3.2% 11/970 1.1% 3/17 17.6% 1/12 8.3% 9/149 6.0% 7/166 4.2% 14/706 2.0%
BY LV FUNCTION
30 day Mortality (mortality/n %)LV Dysfunction
Normal Mild Moderate Severe
7/747 0.9% 7/652 1.1% 12/362 3.3% 19/246 7.7%
MISCELLANEOUS
30 day Mortality (mortality/n %)
Gender Redo Off-pump
Male Female 1st proc Redo Off-pump On-pump
33/1514 2.2% 12/508 2.4% 41/1925 2.1% 4/97 4.1% 2/284 0.7% 43/1738 2.5%
30 day Mortality (mortality/n %)
Smoking Status Diabetes Pre-op creatinine
Current Non or Ex Yes No <=0.2mmol/L >0.2mmol/L
9/281 3.2% 36/1741 2.1% 13/652 2.0% 32/1370 2.3% 39/1968 2.0% 6/52 11.5%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 51 of 834/10/2023
Isolated CABG data
Morbidity
BY AGE
Post-operative complications
Age Group<40
years40-49 yrs 50-59 yrs 60-69 yrs 70-79 yrs 80+ yrs Total
n 14 143 454 636 675 100 2022
New Renal Failure 0.0% 0.7% 2.0% 3.8% 4.3% 8.0% 3.5%
Cerebrovascular complication 0.0% 0.0% 0.0% 0.9% 1.8% 5.0% 1.1%
Permanent Stroke 0.0% 0.0% 0.0% 0.6% 1.2% 1.0% 0.6%
Transient Stroke 0.0% 0.0% 0.0% 0.3% 0.6% 3.0% 0.4%
Continuous Coma 0.0% 0.0% 0.0% 0.2% 0.3% 2.0% 0.2%
Deep Sternal Infection 0.0% 0.0% 0.4% 1.3% 0.9% 1.0% 0.8%
Septicaemia 0.0% 0.0% 0.7% 2.0% 1.0% 3.0% 1.3%
Return to theatre (all cause) 0.0% 3.5% 2.4% 5.5% 4.6% 6.0% 4.4%
Re-op for Bleeding 0.0% 2.1% 0.9% 3.1% 2.1% 2.0% 2.1%
Peri-operative AMI 0.0% 0.7% 0.7% 0.9% 0.6% 4.0% 0.9%
New Cardiac Arrhythmia 7.1% 13.3% 18.7% 28.7% 38.7% 49.0% 29.5%
Pneumonia 0.0% 4.2% 4.2% 3.6% 5.2% 6.0% 4.4%
GIT complication 0.0% 0.0% 1.3% 1.1% 3.1% 7.0% 2.0%
Multi-system Failure 0.0% 0.0% 0.4% 0.8% 0.6% 2.0% 0.6%
Anticoagulant complication 0.0% 1.4% 0.0% 0.5% 0.9% 0.0% 0.5%
Red Blood Cells transfused 14.3% 19.6% 22.2% 36.9% 46.5% 64.0% 36.8%
Non-RBC blood products 0.0% 16.1% 10.4% 21.4% 21.0% 24.0% 18.4%
Post-operative indicators
Intubation Time <=10hrs 69.2% 79.1% 73.5% 66.7% 61.3% 56.1% 66.8%
10-20hrs 23.1% 16.5% 20.4% 25.4% 27.6% 29.6% 24.6%
>20hrs 7.7% 4.3% 6.2% 7.9% 11.1% 14.3% 8.7%
Post-op Length of Stay
<= 5 days 78.6% 49.0% 48.5% 31.6% 20.7% 15.0% 32.5%
5-10 days 21.4% 48.3% 46.3% 57.7% 63.9% 56.0% 56.2%
>10 days 0.0% 2.8% 5.3% 10.7% 15.4% 29.0% 11.3%
Intensive Care Stay
<=24hrs 85.7% 69.2% 67.6% 60.7% 57.5% 45.9% 61.3%
>24hrs –4 days
14.3% 28.7% 29.3% 34.2% 36.8% 40.8% 33.8%
> 4 days 0.0% 2.1% 3.1% 5.1% 5.6% 13.3% 5.0%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 52 of 834/10/2023
Isolated CABG data
Morbidity
BY OPERATIVE STATUS
Post-operative complications
Operative Status
Elective Urgent Emergency Salvage Total
n 1267 675 73 7 2022
New Renal Failure 3.4% 3.3% 6.8% 14.3% 3.5%
Cerebrovascular complication 1.0% 1.0% 4.1% 0.0% 1.1%
Permanent Stroke 0.6% 0.4% 2.7% 0.0% 0.6%
Transient Stroke 0.4% 0.4% 1.4% 0.0% 0.4%
Continuous Coma 0.2% 0.1% 1.4% 0.0% 0.2%
Deep Sternal Infection 0.6% 1.2% 1.4% 0.0% 0.8%
Septicaemia 1.1% 1.2% 4.1% 14.3% 1.3%
Return to theatre (all cause) 3.8% 4.6% 12.3% 0.0% 4.4%
Re-op for Bleeding 2.1% 1.9% 5.4% 0.0% 2.1%
Peri-operative AMI 0.8% 0.9% 1.4% 14.3% 0.9%
New Cardiac Arrhythmia 29.5% 28.7% 37.0% 42.9% 29.5%
Pneumonia 3.5% 5.0% 11.0% 42.9% 4.4%
GIT complication 1.8% 2.4% 2.7% 0.0% 2.0%
Multi-system Failure 0.4% 0.7% 4.1% 0.0% 0.6%
Anticoagulant complication 0.4% 0.3% 5.5% 0.0% 0.5%
Red Blood Cells transfused 33.9% 38.8% 63.0% 85.7% 36.8%
Non-RBC blood products 17.5% 16.4% 46.6% 71.4% 18.4%
Post-operative indicators
Intubation Time <=10hrs 69.5% 65.0% 43.1% 0.0% 66.8%
10-20hrs 23.6% 26.4% 25.0% 28.6% 24.6%
>20hrs 6.9% 8.6% 31.9% 71.4% 8.7%
Post-op Length of Stay
<= 5 days 34.6% 29.6% 23.3% 28.6% 32.5%
5-10 days 56.6% 56.1% 50.7% 42.9% 56.2%
>10 days 8.8% 14.2% 26.0% 28.6% 11.3%
Intensive Care Stay
<=24hrs 61.9% 62.9% 38.9% 14.3% 61.3%
>24hrs –4 days
34.8% 31.4% 34.7% 71.4% 33.8%
> 4 days 3.3% 5.7% 26.4% 14.3% 5.0%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 53 of 834/10/2023
Isolated CABG data
Morbidity
BY OPERATIVE STATUS AND CARDIAC SURGERY UNIT
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 54 of 834/10/2023
No. cases
A 405B 347C 307D 195E 250F 518
Total 2022
Isolated CABG data
Morbidity
BY PRE-OPERATIVE AMI
Post-operative complications
Pre-op AMI Time since AMI Total
Yes No <6hrs 6-24hrs 1-7days7-
21days>21days
n 1051 970 17 12 149 166 706 2022
New Renal Failure 4.1% 2.9% 5.9% 0.0% 6.7% 3.0% 3.8% 3.5%
Cerebrovascular complication 1.1% 1.1% 0.0% 0.0% 1.3% 0.0% 1.4% 1.1%
Permanent Stroke 0.7% 0.6% 0.0% 0.0% 0.7% 0.0% 0.9% 0.6%
Transient Stroke 0.5% 0.4% 0.0% 0.0% 0.7% 0.0% 0.6% 0.4%
Continuous Coma 0.3% 0.2% 0.0% 0.0% 0.7% 0.0% 0.3% 0.2%
Deep Sternal Infection 1.0% 0.6% 0.0% 0.0% 1.3% 0.6% 1.1% 0.8%
Septicaemia 1.3% 1.2% 0.0% 0.0% 1.3% 1.8% 1.3% 1.3%
Return to theatre (all cause) 4.9% 3.7% 5.9% 8.3% 9.4% 0.6% 4.8% 4.3%
Re-op for Bleeding 2.1% 2.1% 5.9% 0.0% 2.7% 0.0% 2.4% 2.1%
Peri-operative AMI 1.3% 0.4% 5.9% 8.3% 1.3% 1.8% 1.0% 0.9%
New Cardiac Arrhythmia 28.1% 31.1% 47.1% 33.3% 24.2% 24.1% 29.2% 29.6%
Pneumonia 4.8% 4.0% 11.8% 16.7% 6.7% 5.4% 3.8% 4.4%
GIT complication 1.5% 2.6% 0.0% 0.0% 2.7% 1.2% 1.4% 2.0%
Multi-system Failure 0.9% 0.4% 0.0% 8.3% 2.0% 0.6% 0.6% 0.6%
Anticoagulant complication 0.3% 0.8% 11.8% 0.0% 0.0% 0.6% 0.0% 0.5%
Red Blood Cells transfused 38.7% 34.6% 64.7% 58.3% 43.0% 36.1% 37.3% 36.7%
Non-RBC blood products 19.0% 17.6% 58.8% 41.7% 22.1% 13.3% 18.4% 19.1%
Post-operative indicators
Intubation Time <=10hrs 64.8% 68.9% 29.4% 33.3% 57.2% 71.8% 66.3% 66.8%
10-20hrs 24.8% 24.4% 29.4% 33.3% 25.5% 20.9% 25.3% 24.6%
>20hrs 10.3% 6.7% 41.2% 33.3% 17.2% 7.4% 8.4% 8.6%
Post-op Length of Stay
<= 5 days 31.4% 33.7% 29.4% 16.7% 30.9% 37.3% 30.5% 32.5%
5-10 days 56.1% 56.3% 52.9% 58.3% 47.7% 51.8% 58.9% 56.2%
>10 days 12.5% 10.0% 17.6% 25.0% 21.5% 10.8% 10.6% 11.3%
Intensive Care Stay
<=24hrs 58.1% 64.8% 41.2% 41.7% 56.2% 59.4% 58.8% 61.3%
>24hrs –4 days
36.0% 31.4% 35.3% 41.7% 30.8% 35.8% 37.1% 33.8%
> 4 days 6.0% 3.8% 23.5% 16.7% 13.0% 4.8% 4.1% 4.9%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 55 of 834/10/2023
Isolated CABG data
Morbidity
MISCELLANEOUS
Post-operative complications
Gender Redo Off-pump Pre-op creatinine Total
Male Female 1st proc RedoOff-
pumpOn-
pump<=0.2mmol/L
>0.2mmol/L
n 1514 508 1925 97 284 1738 1968 52 2022
New Renal Failure 3.2% 4.3% 3.4% 5.2% 3.2% 3.6% 3.1% 17.3% 3.5%
Cerebrovascular complication
1.2% 1.0% 1.1% 1.0% 0.7% 1.2% 1.1% 3.8% 1.1%
Permanent Stroke 0.6% 0.8% 0.7% 0.0% 0.4% 0.7% 0.6% 3.8% 0.6%
Transient Stroke 0.6% 0.0% 0.5% 0.0% 0.4% 0.5% 0.5% 0.0% 0.4%
Continuous Coma 0.1% 0.6% 0.2% 1.0% 0.0% 0.3% 0.3% 0.0% 0.2%
Deep Sternal Infection 0.8% 1.0% 0.8% 2.1% 0.4% 0.9% 0.8% 3.8% 0.8%
Septicaemia 1.2% 1.6% 1.2% 3.1% 0.7% 1.4% 1.1% 9.6% 1.3%
Return to theatre (all cause) 4.3% 4.5% 4.2% 7.3% 2.8% 4.6% 4.2% 9.6% 4.4%
Re-op for Bleeding 2.4% 1.4% 2.1% 2.1% 1.4% 2.2% 2.1% 1.9% 2.1%
Peri-operative AMI 0.9% 1.0% 0.9% 0.0% 0.7% 0.9% 0.9% 0.0% 0.9%
New Cardiac Arrhythmia 28.9% 31.5% 29.6% 29.2% 22.2% 30.7% 29.4% 34.6% 29.5%
Pneumonia 4.1% 5.3% 4.4% 5.2% 2.8% 4.7% 4.3% 9.6% 4.4%
GIT complication 2.0% 2.0% 2.0% 2.1% 1.8% 2.1% 2.0% 3.8% 2.0%
Multi-system Failure 0.5% 1.2% 0.6% 1.0% 0.0% 0.7% 0.6% 1.9% 0.6%
Anticoagulant complication 0.7% 0.2% 0.6% 0.0% 0.0% 0.6% 0.6% 0.0% 0.5%
Red Blood Cells transfused 32.5% 49.4% 36.6% 40.6% 16.2% 40.1% 36.1% 59.6% 36.8%
Non-RBC blood products 19.4% 15.4% 18.2% 22.9% 4.6% 20.7% 18.1% 25.0% 18.4%
Post-operative indicators
Intubation Time <=10hrs 68.5% 61.6% 67.3% 55.8% 81.6% 64.5% 67.2% 51.0% 66.8%
10-20hrs 23.1% 28.9% 24.4% 28.4% 15.3% 26.0% 24.2% 37.3% 24.6%
>20hrs 8.4% 9.4% 8.3% 15.8% 3.1% 9.5% 8.5% 11.8% 8.7%
Post-op Length of Stay
<= 5 days 34.7% 25.8% 33.1% 20.6% 51.8% 29.3% 32.9% 17.3% 32.5%
5-10 days 55.2% 59.1% 55.8% 63.9% 40.8% 58.7% 56.6% 42.3% 56.2%
>10 days 10.0% 15.2% 11.1% 15.5% 7.4% 12.0% 10.5% 40.4% 11.3%
Intensive Care Stay
<=24hrs 62.3% 58.1% 61.4% 58.3% 61.2% 61.3% 61.7% 45.1% 61.3%
>24hrs –4 days
33.2% 35.4% 33.9% 31.3% 36.6% 33.3% 33.9% 31.4% 33.8%
> 4 days 4.5% 6.5% 4.7% 10.4% 2.2% 5.4% 4.5% 23.5% 5.0%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 56 of 834/10/2023
Other Group data
Total number of procedures Mortality (30 days post op) by procedure
Surgery type (NOT mutually exclusive)
Number of procedures
% of total procedures
Number of patients
% of Surgery type
Left Ventricular Aneurysm 31 1.2% 2 6.5%Acquired VSD 8 1.2% 2 25.0%
Aortic 98 3.3% 13 13.3%
Aneurysm – Asc only 41 1.4% 0 0.0%
– Asc + arch 9 0.3% 0 0.0%
– Arch only 0 0.0%
– Desc 3 0.1% 0 0.0%
– Thor/abd only 5 0.2% 3 60.0%
– Other 2 0.1% 0 0.0%
Disection – Asc – Acute 28 0.9% 9 32.1%
– Asc – Chronic 2 0.1% 0 0.0%
– Desc – Acute 2 0.1% 0 0.0%
– Desc – Chronic 1 <0.1% 0 0.0%Acute Traumatic Aortic Transection
8 0.3% 1 12.5%
Congenital - ASD 28 0.9% 1 2.9%
- Other 14 0.5% 0 0.0%
Cardiac Trauma 8 0.3% 3 37.5%
Pericardiectomy 6 0.2% 0 0.0%
Cardiac Tumour 11 0.4% 0 0.0%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 57 of 834/10/2023
Factors contributing to Morbidity in the Whole Population
BY AGE
Age Group<40
years40-49 yrs 50-59 yrs 60-69 yrs 70-79 yrs 80+ yrs Total
n 106 214 586 894 981 193 2974
New Renal Failure 5.7% 3.8% 3.4% 4.9% 6.8% 13.5% 5.8%
Cerebrovascular complication 1.9% 2.3% 0.5% 2.5% 2.7% 5.2% 2.3%
Permanent Stroke 1.0% 1.4% 0.3% 1.6% 1.5% 2.1% 1.3%
Transient Stroke 0.0% 0.0% 0.0% 0.8% 0.7% 2.6% 0.6%
Continuous Coma 1.0% 1.9% 0.2% 0.3% 0.6% 1.0% 0.6%
Deep Sternal Infection 0.0% 0.5% 0.5% 1.0% 0.8% 0.5% 0.7%
Re-op for Bleeding 7.5% 3.3% 1.5% 4.0% 2.9% 3.1% 3.2%
Intubation Time <=10hrs 50.5% 72.1% 68.7% 62.4% 56.2% 50.5% 61.1%
10-20hrs 19.2% 15.9% 22.3% 25.8% 29.8% 30.0% 25.8%
>20hrs 30.3% 12.0% 9.0% 11.8% 14.0% 19.5% 13.2%
Post-op Length of Stay
<= 5 days 31.1% 41.6% 42.0% 27.0% 18.1% 11.9% 27.2%
5-10 days 29.2% 47.2% 46.4% 55.7% 61.0% 56.0% 54.1%
>10 days 39.6% 11.2% 11.6% 17.3% 20.9% 32.1% 18.7%
Intensive Care Stay
<=24hrs 40.8% 58.2% 63.0% 55.3% 52.9% 36.6% 54.5%
>24hrs –4 days
37.9% 33.3% 31.2% 36.3% 38.8% 47.6% 36.7%
> 4 days 21.4% 8.5% 5.9% 8.5% 8.3% 15.7% 8.8%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 58 of 834/10/2023
Factors contributing to Morbidity in the Whole Population
BY PROCEDURE TYPE
Procedure TypeIsolated CABG
Valve(s) onlyValve(s) +
CABGOther Total
n 2022 366 238 348 2974
New Renal Failure 3.5% 4.1% 10.9% 17.1% 5.8%
Deep Sternal Infection 0.8% 0.0% 0.8% 0.9% 0.7%
Re-op for Bleeding 2.1% 5.7% 4.6% 5.5% 3.2%
Red Blood Cells transfused 36.8% 43.4% 66.4% 59.2% 42.6%
Non-RBC blood products transfused
18.4% 28.4% 44.1% 49.4% 25.3%
Intubation Time <=10hrs 66.8% 61.2% 44.7% 39.0% 61.1%
10-20hrs 24.6% 29.1% 32.5% 24.3% 25.8%
>20hrs 8.7% 9.7% 22.8% 36.6% 13.2%
Post-op Length of Stay
<= 5 days 32.5% 17.2% 9.2% 19.5% 27.2%
5-10 days 56.2% 60.7% 51.7% 36.5% 54.1%
>10 days 11.3% 22.1% 39.1% 44.0% 18.7%
Intensive Care Stay
<=24hrs 61.3% 53.0% 34.2% 30.2% 54.5%
>24hrs – 4 days
33.8% 39.6% 48.9% 42.3% 36.7%
> 4 days 5.0% 7.4% 16.9% 27.5% 8.8%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 59 of 834/10/2023
Factors contributing to Morbidity in the Whole Population
BY LV FUNCTION
LV Dysfunction
Normal Mild Moderate Severe Total
n 1177 875 490 380 2922
New Renal Failure 4.0% 4.1% 8.6% 9.7% 5.5%
Cerebrovascular complication 2.3% 1.9% 2.2% 2.6% 2.2%
Permanent Stroke 1.3% 1.1% 1.6% 1.3% 1.3%
Transient Stroke 0.8% 0.8% 0.2% 0.3% 0.6%
Continuous Coma 0.4% 0.2% 0.6% 1.3% 0.5%
Intubation Time <=10hrs 63.5% 65.4% 56.5% 52.0% 61.4%
10-20hrs 27.1% 25.1% 29.3% 19.3% 25.9%
>20hrs 9.4% 9.5% 14.1% 28.6% 12.7%
Post-op Length of Stay
<= 5 days 29.4% 28.8% 20.0% 26.9% 27.3%
5-10 days 54.6% 55.3% 59.9% 44.9% 54.4%
>10 days 16.0% 15.9% 20.2% 28.2% 18.3%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 60 of 834/10/2023
Factors contributing to Morbidity in the Whole Population
BY DIABETES
Diabetes
Yes No Total
n 827 2144 2971
Cerebrovascular complication 1.7% 2.5% 2.3%
Permanent Stroke 1.5% 1.3% 1.3%
Transient Stroke 0.1% 0.8% 0.6%
Continuous Coma 0.2% 0.7% 0.6%
Deep Sternal Infection 1.6% 0.4% 1.7%
BY STATUS
Operative Status
Elective Urgent Emergency Salvage Total
n 1908 886 155 25 2974
Cerebrovascular complication 1.7% 2.0% 10.3% 8.0% 2.3%
Stroke permanent 1.1% 1.0% 5.2% 4.5% 1.3%
Transient Stroke 0.6% 0.7% 1.3% 0.0% 0.6%
Continuous Coma 0.2% 0.3% 5.8% 9.1% 0.6%
Re-op for Bleeding 3.0% 2.5% 7.1% 16.0% 3.2%
Post-op Length of Stay
<= 5 days 28.4% 25.8% 18.7% 40.0% 27.2%
5-10 days 58.0% 50.5% 32.9% 16.0% 54.1%
>10 days 13.6% 23.7% 48.4% 44.0% 18.7%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 61 of 834/10/2023
Factors contributing to Morbidity in the Whole Population
BY REDO
Redo
1st Proc Redo Total
n 2743 231 2974
Re-op for Bleeding 3.1 3.5 3.2
Intubation Time <=10hrs 62.3% 46.0% 61.1%
10-20hrs 25.8% 25.9% 25.8%
>20hrs 11.9% 28.1% 13.2%
Post-op Length of Stay
<= 5 days 28.3% 15.2% 27.2%
5-10 days 54.4% 50.6% 54.1%
>10 days 17.4% 34.2% 18.7%
BY RESPIRATORY DISEASE
Respiratory Disease
No Mild Moderate Severe Total
n 2458 408 75 27 2968
Deep Sternal Infection 0.6% 1.5% 1.3% 0.0% .7%
Intubation Time <=10hrs 61.8% 60.2% 49.3% 38.5% 61.1%
10-20hrs 25.8% 24.1% 33.3% 23.1% 25.8%
>20hrs 12.3% 15.7% 17.3% 38.5% 13.2%
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 62 of 834/10/2023
Factors contributing to Morbidity in the Whole Population
MISCELLANEOUS
Previous Cerebrovascular Disease Atrial Arrythmia
Yes No Total Yes No Total
n 319 2651 2970 319 2655 2974
Cerebrovascular complication 5.3% 1.9% 2.3% 4.7% 2.0% 2.3%
Permanent Stroke 2.5% 1.2% 1.3% 2.2% 1.2% 1.3%
Transient Stroke 1.3% 0.6% 0.6% 0.6% 0.6% 0.6%
Continuous Coma 2.5% 0.3% 0.5% 2.2% 0.4% 0.6%
CPB time0 hrs >0 - 1hr >1 – 3 hrs >3 hrs Total
n 308 139 2272 274 2973
Cerebrovascular complication 0.6% 0.0% 1.7% 9.5% 2.3%
Permanent Stroke 0.3% 0.0% 1.1% 5.2% 1.3%
Transient Stroke 0.3% 0.0% 0.5% 2.6% 0.6%
Continuous Coma 0.0% 0.0% 0.4% 3.0% 0.6%
BITA ObesityReturn to theatre
(all cause)
Yes No Total Yes No Total Yes No Total
n 318 2652 2970 186 2784 2970 848 2122 2970
Deep Sternal Infection 2.5% 0.5% 0.7% 7.0% 0.3% 0.7% 1.1% 0.6% 0.7%
Pre-op anti-plateletYes No Total
n 1226 1746 1972
Re-op for bleeding 3.3 3.1 3.2
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 63 of 834/10/2023
The ASCTS Database software contains an In-House reporting module, which
provides a report on case numbers and outcomes for the individual unit as required.
The following pages display a copy of that report generated by the same software, but
for all units data combined.
The report is provided here to allow individual units to compare the report generated
at their own site to that from the whole state.
PLEASE NOTE: minor discrepancies between the report from the In-House reporting
module and the Comprehensive Surgeon’s Report are the result of differences in
filtering processes prior to analysis whereby cases are excluded.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 64 of 834/10/2023
In-house reporting module – report from all units combined
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 72 of 834/10/2023
The following pages outline formal processes relating to the conduct of the project.
These include:
Data management
Peer Review mechanism
Data collection form
Patient Information Sheet
Opt-off procedure
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 73 of 834/10/2023
Processes
Data Management
All data collected as part of the ASCTS project is forwarded to the Baker Heart
Research Institute. The flow of information into the data centre is outlined in the
following figure.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 74 of 834/10/2023
Surgical Unit
Surgical Unit
Surgical Unit
Surgical Unit
Surgical Unit
Interim
Unit
Registry
ErrorCorrection
Final
Unit
Registry
Merged
State
Registry
Current Peer Review Mechanism for identification of Unit outliers
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 75 of 834/10/2023
STEP 1: Identification of outlier on Control ChartWeek 0
STEP 2: Unit contacted and asked to undertake internal review of the past 3 months data and report within 4 weeksWeek 4
STEP 3: CDA reviews local audit report and discusses results with UnitWeek 8
STEP 4: Review most recent KPI data: Result within limits - No action requiredKPI remains out of rangeWeek 12
STEP 5: Unit contacted and asked to agree to external review of the past 3 months data and report within 4 weeksWeek 16
STEP 6: CDA reviews external audit report and discusses results with UnitWeek 20
STEP 7: Review most recent KPI data: Result within limits - No action requiredKPI remains out of rangeWeek 24
STEP 8: Unit contacted and meeting arranged with hospital administration and Department of Health
Data Collection Form
GENERAL DESCRIPTIONThe following pages show the ASCTS Data Collection Form. This form contains only the ASCTS Minimum Dataset. Individual Hospitals may have a slightly different form depending on the type and amount of additional data each Hospital wishes to collect.
The ASCTS Data collection form consists of 3 parts: Pre operative, Intra Operative and Post Operative.
Pre Operative: We recommend that this section of the form should be completed by the Resident. This part of the form contains information on the patient’s demographics, risk factors, pre operative cardiac status and previous interventions.
Intra Operative: We recommend that this section of the form should be completed by the Surgeon.This part of the form contains information on the patient’s haemodynamic data, operative status, and information directly related to the procedure performed.
Post Operative:We recommend that this section of the form should be completed by the Registrar.This part of the form contains information on post operative complications and mortality.
We also recommend that the Data Manager check all parts of the form for completeness and make any amendment as required.
Each part is contained on separate pages from the other parts. They can therefore be separated from each other for the purposes of data collection if required.
IMPORTANT INSTRUCTIONS FOR FILLING IN THE FORMSThe form has been designed for the purposes of scanning. During the first phase of the project the form will be submitted to The Baker Institute for the purposes of data entry into the ASCTS Database. As a scan form it is important that the form be completed in the following manner:
Complete the form with an ink pen (preferably black). Enter any values such as numbers or letters within the boxes, with one character per box. Enter letters and block letters (capitals). Shade in the circles for yes/no questions and multiple-choice questions. Do NOT tick or
cross them.
SUBMISSION OF DATA TO THE ASCTS PROJECTWhen all 3 parts of the form have been completed and checked this should be indicated on the top of the first page. The entire form should then be faxed to 1800 650 573.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 76 of 834/10/2023
Data Collection Form – Pre Operative page 1
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 77 of 834/10/2023
Data Collection Form – Pre Operative page 2
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 78 of 834/10/2023
Data Collection Form – Intra Operative page 1
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 79 of 834/10/2023
Data Collection Form – Intra Operative page 2
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 80 of 834/10/2023
Data Collection Form – Post Operative
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 81 of 834/10/2023
Patient Information Sheet
ADULT CARDIAC SURGERY DATABASE
IntroductionYou are about to have a cardiac surgery operation. Generally heart surgery is successful in improving the quality and length of the patient’s life, with a small risk of death or major complications. However, in certain people the surgery is less successful. This may be due to some people having characteristics that increase their risk of complications, or it may be due to the type of operation done and the circumstances in which it is performed.
In order to improve the success of heart surgery we need to know what factors increase a patient’s risk of complications, and which surgical procedures have the most successful outcome. To achieve this, the Victorian branch of the Australian Society of Cardiac and Thoracic Surgeons (ASCTS) has set up a Cardiac Surgery Database to monitor the results of cardiac operations.
The database aims to record information on every adult having a cardiac surgery operation. The success of the database depends on the amount of data we collect. We are asking you to participate in the Cardiac Surgery Database, by allowing us to document information relevant to your operation.
What Information Do We Need?The information we require includes your name, date of birth, Medicare Number, hospital identification number, the name of the hospital the reason you are having cardiac surgery and other information directly related to your proposed operation. All of your information will be freely available to you.
We Will Keep Your Information ConfidentialYour personal information is confidential and cannot be used outside the database. Procedures are in place to protect your information and keep it confidential. Registry data is accessible by authorised staff of the Cardiac Surgery Database project. Aggregate data will be made available through the reporting system of ASCTS. You cannot be identified in any reports produced by the registry.
How We Will Collect The Information?You are not required to do anything. The hospital staff will complete the forms that contain your details during your hospital stay. The information will be entered onto the database computer.
Risk And Benefits – To YouYour information is protected and we are not allowed to identify you by law. The database will produce general reports on the success of surgery which we anticipate will improve the quality of cardiac surgery in the future. Having your data entered into the Database will not alter the care and treatment you receive for your current surgery in any way.
You Can Choose Not To Be In The DatabaseWe understand that not everyone is comfortable about having details related to their cardiac condition documented in a database. If you feel this way, and do not want this information added to the database, please contact the Project Co-ordinator on 1800 998 722 within two weeks of the operation. (You can always have your information removed from the database later simply by contacting the Project Co-ordinator) A decision on whether or not you wish to be involved in the registry does not affect your treatment in any way.
If you have any questions, concerns or require further information about the Cardiac Surgery Database, please do not hesitate to contact the Project Co-ordinator on 1800 998 722.
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 82 of 834/10/2023
Consent procedure
In order to “Opt-off” from the ACST Cardiac Surgery Project, the patient, or their representative must call the 1800 number provided to him/her on the Patient Information Sheet.
An “Opt-off” cannot be done by staff at the hospital where the patient is undergoing the cardiac procedure.
The following procedure will be followed by the Project Manager when patient’s ring the 1800 number to request that they not be included in the ASCTS Cardiac Surgery Project. This is provided here in case the patient wishes to have more information about the Opt-off procedure prior to calling the 1800 number.
Procedure For Processing Opt-Out Requests
1. Obtain Name, date of birth, Hospital where surgery was performed, approximate date that surgery was performed and contact phone number. (in order to identify the record to be deleted).
2. Ask if the patient has any questions about the database or would like any further explanation of how and why the data is collected.
3. Ask the Patient “Would you like me to not add your information to the Register?”
4. Ask the patient “You do not have to tell me, but may I ask you why you would not like your information to be included in the database?”
5. After receiving the answer to the above question DO NOT offer any more explanations or try to change the patient’s mind – the patient’s decision is final.
6. Thank the patient – notify them that if they undergo a new surgical procedure they will need to Opt-off again. We will not be retaining the patient’s details if the data is not added – We will however retain the information that a patient who underwent a surgical procedure at that hospital in the calendar month of the Date of Surgery withdrew their data from the database, and the reasons for withdrawal.
7. Check the database for the appropriate record. If a near match is found but not sure then contact the patient to confirm. If a match is not found then retain the information until the record arrives (records will not be received until at least 1 month post surgery).
ASCTS Surgeon’s Comprehensive report 2001-2002 Page 83 of 834/10/2023